person

Christophe M.

Country
Belgium
Department
Gastroenterology, Hepato-Pancreatology and Digestive Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
190
Sites with multiple studies

Has run more than one trial at 190 of 359 partner sites.

Specializations

Liver Disease Specialization

This investigator demonstrates extensive expertise in treating non-alcoholic steatohepatitis (NASH) and related metabolic liver conditions. Their research encompasses both early-stage disease and advanced liver fibrosis, with particular focus on innovative therapeutic approaches.

  • NASH and Metabolic Liver Disease
  • Liver Fibrosis Management
  • Compensated Cirrhosis

Chronic Liver Conditions

The investigator specializes in treating various chronic liver diseases, including primary biliary cholangitis (PBC) and chronic viral hepatitis. Their work extends to managing complications such as portal hypertension and cholestatic conditions.

  • Viral Hepatitis Treatment
  • Cholestatic Disorders
  • Portal Hypertension Management

Advanced Therapeutic Applications

The investigator focuses on evaluating novel therapeutic agents for liver diseases, including combination therapy approaches and treatments for metabolic dysfunction-associated steatohepatitis (MASH). Their expertise extends to investigating treatments for various stages of liver disease progression.

  • Novel Therapeutic Evaluation
  • Combination Treatment Strategies
  • Disease Progression Management

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.